SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: idahoranch112/20/2020 6:47:01 PM
5 Recommendations

Recommended By
erippetoe
lafdsmokey
Olecranon
patlawche11
samcat500

  Read Replies (5) of 63324
 
griproom.com

“ Gilead didn’t buy Trodelvy just to treat breast cancer. They’re doing research on a broad number of tumors. Trodelvy could become the best-selling cancer drug of all time.”

It’s an opinion piece, but still interesting. The above statement is also the opinion of many old timers here, emphasis on “could be”.

I’m going to hold onto 5k shares of GILD for nostalgia’s sake if nothing else.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News